Low bone mass in microscopic colitis

BMC Gastroenterology

Table 1 Clinical characteristics of patient groups.

	Microscopic colitis (10 LC and 2 CC)		Crohn's disease
duration of disease (years)	4.33 ± 1.66	ns.	5.03 ± 3.53
actual symptoms (number of liquid stools/day)	1.41 ± 0.66	ns.	1.37 ± 0.49
budesonide in the past	11/14 (78.5%)	p < 0.01	11/28 (39.28%)
systemic steroid ever	none		14/28 (50%)
actual immunosuppressants	none		9/28 (32.14%)

Subjects in the healthy control (HC) group had not been treated with medications containing steroids or immunosuppressants, and they were symptomless. The results are presented as mean ± standard deviation; Student's t-tests were applied for statistical analysis. (LC = lymphocytic colitis, CC = collagenous colitis, ns = not significant.)

ISSN: 1471-230X